In this regard, it is relevant that mammalian cells lacking the major hereditary breast/ovarian cancer predisposition genes BRCA1 or BRCA2 or other cancer predisposition HR genes reveal a bias towards LTGC [28, 31–34]. The gene discussed is BRCA2; the disease is ovarian cancer.